Concepedia

Xiaojuan Lian

XL

Statistics

Publications

11

Citations

657

H-Index

11

Active since

2017

Affiliations

Jiangjin Central Hospital(Current)

Sinovac Biotech

National Institutes for Food and Drug Control

Daping Hospital

Hebei Provincial Center for Disease Control and Prevention

Xiaojuan Lian is an author at Jiangjin Central Hospital specializing in oncology, medicine, and molecular oncology.

Publications per year

2017–2023

11

Publications

11

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

Bihua Han, Yufei Song, Changgui Li et al. · The Lancet Infectious Diseases · 2021 · 355 citations · Full text

Veterinary Medicine, Immunology, Pediatrics +16

Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · medRxiv · 2020 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Genistein promotes ionizing radiation-induced cell death by reducing cytoplasmic Bcl-xL levels in non-small cell lung cancer

Zhimin Zhang, Feng Jin, Xiaojuan Lian et al. · Scientific Reports · 2018 · 48 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Role of PARP1-mediated autophagy in EGFR-TKI resistance in non-small cell lung cancer

Zhimin Zhang, Xiaojuan Lian, Wei Xie et al. · Scientific Reports · 2020 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

Transforming growth factor-β1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cells

Yan Qi, Ning Wang, Yong-Lai He et al. · PLoS ONE · 2017 · 23 citations · Full text

Life Sciences, Cell Biology, Oncology +17

1–5 of 11